Furthermore, in parallel to the increased expression of PD-1 and PD-L1, a high expression of CTLA-4 was observed on tumor cells treated with PD-1/PD-L1 antagonists, whereas a decreased expression was detected in case of PD-1/PD-L1 agonistic treatments. Here, CTLA4 is linked to neoplasm.